BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//HCV Free Florida - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HCV Free Florida
X-ORIGINAL-URL:https://hcvfreefl.org
X-WR-CALDESC:Events for HCV Free Florida
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20211013T080000
DTEND;TZID=UTC:20211015T170000
DTSTAMP:20260525T225925
CREATED:20210817T212336Z
LAST-MODIFIED:20210823T162332Z
UID:558-1634112000-1634317200@hcvfreefl.org
SUMMARY:INHSU 2021 Virtual Conference
DESCRIPTION:At #INHSU2021 you'll have the chance to hear from experts in epidemiology and public health in #hepatitisC\, other infectious diseases\, and the broader health of #peoplewhousedrugs. Secure your virtual or in-person ticket today https://t.co/olRs43ZrIc #WorldHepatitisDay pic.twitter.com/1VnhWjYEJO \n— INHSU (@INHepSU) July 28\, 2021
URL:https://hcvfreefl.org/event/inhsu-2021-virtual-conference/
LOCATION:Novotel Sydney Manly Pacific\, 55 N Steyne\, Manly NSW 2095\, Australia
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20211014T150000
DTEND;TZID=UTC:20211014T160000
DTSTAMP:20260525T225925
CREATED:20210709T165335Z
LAST-MODIFIED:20210726T170439Z
UID:548-1634223600-1634227200@hcvfreefl.org
SUMMARY:Moving from Hepatitis Discovery to Elimination: NIH Webinar Series on Research Advancing Hepatitis Elimination
DESCRIPTION:The United States National Institutes of Health (NIH) is committed to setting research priorities that advance progress toward viral hepatitis elimination. In 2020\, Dr. Harvey Alter\, NIH researcher\, was awarded the Nobel Prize in Medicine and Physiology for his contributions to the discovery of HCV\, exemplifying the importance of NIH to hepatitis elimination efforts. \nNIH and the Coalition for Global Hepatitis Elimination are launching a new webinar series\, “Moving from Hepatitis Discovery to Elimination” to highlight ongoing research that can benefit elimination efforts\, support translation of research into implementation\, and identify additional research needs. \nFourth Webinar: July 8th\, 3-5 pm ET\nImproving Early Detection of Hepatocellular Carcinoma (HCC): The Quest for New Biomarkers\nHosted by the National Cancer Institute \nCurrent guidelines (e.g. AASLD) recommend biannual (every 6 months) surveillance for hepatocellular carcinoma (HCC)\, usually using ultrasound (US) which may or may not include measuring the marker\, AFP (alpha-fetoprotein). This is recommended for certain chronic liver diseases (e.g. HBV infected individuals) and also for individuals with cirrhosis. These surveillance recommendations achieve mixed results in their effectiveness for early detection of HCC. There is an unmet need to identify and implement more effective surveillance (e.g. imaging and biomarkers) for the early detection of HCC. This webinar will explore the challenges and opportunities for improving HCC surveillance. \nPresentations:\nGlobal Dimension of HCC and Epidemiology- Katherine McGlynn\, National Cancer Institute (NCI) \nHCC Surveillance Current Practices- Amit Singal\, UT Southwestern Medical Center \nBiomarkers for HCC- Anand Mehta\, Medical University of South Carolina \nRisk Assessment of HCC- Nabihah Tayob\, Dana-Farber Cancer Institute and Harvard Medical School \nBasic HCC Research: Mouse Models- Ray Chung\, Massachusetts General Hospital
URL:https://hcvfreefl.org/event/moving-from-hepatitis-discovery-to-elimination-nih-webinar-series-on-research-advancing-hepatitis-elimination-2/
END:VEVENT
END:VCALENDAR